Deutsche Bank lowered the firm’s price target on BWX Technologies to $107 from $110 and keeps a Buy rating on the shares. The firm cites reduced 2026 free cash flow estimates for the target drop. The analyst updated the firm’s Government Operations forecasts for the potential push-out of the CVN-82 procurement, resulting in a 6% downward revision to its 2026 earnings estimate.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWXT:
- BWX Technologies submits Drug Master File to FDA for Actinium-225 API
- BWX Technologies initiated with a Buy at CLSA
- BWX Technologies price target lowered to $110 from $111 at Deutsche Bank
- BWX Technologies affirms FY24 EPS view of $3.05-$3.20, consensus $3.14
- BWX Technologies reports Q1 EPS 76c, consensus 69c